Compass Pathways Plc (CMPS)
8.87
-0.25
(-2.74%)
USD |
NASDAQ |
Nov 13, 11:11
Compass Pathways Enterprise Value : 902.15M for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 902.15M |
| November 11, 2026 | 927.65M |
| November 10, 2026 | 920.57M |
| November 09, 2026 | 910.65M |
| November 06, 2026 | 829.89M |
| November 05, 2026 | 716.55M |
| November 04, 2026 | 828.48M |
| November 03, 2026 | 827.06M |
| November 02, 2026 | 801.56M |
| October 30, 2026 | 1.249B |
| October 29, 2026 | 1.337B |
| October 28, 2026 | 1.350B |
| October 27, 2026 | 1.283B |
| October 26, 2026 | 1.176B |
| October 23, 2026 | 1.194B |
| October 22, 2026 | 1.258B |
| October 21, 2026 | 1.288B |
| October 20, 2026 | 1.296B |
| October 19, 2026 | 1.184B |
| October 16, 2026 | 1.133B |
| October 15, 2026 | 1.256B |
| October 14, 2026 | 1.207B |
| October 13, 2026 | 1.188B |
| October 12, 2026 | 1.244B |
| October 09, 2026 | 1.310B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.235B |
| October 07, 2026 | 1.266B |
| October 06, 2026 | 1.248B |
| October 05, 2026 | 1.254B |
| October 02, 2026 | 1.296B |
| October 01, 2026 | 1.303B |
| September 30, 2026 | 1.373B |
| September 29, 2026 | 1.380B |
| September 28, 2026 | 1.417B |
| September 25, 2026 | 1.393B |
| September 24, 2026 | 1.398B |
| September 23, 2026 | 1.487B |
| September 22, 2026 | 1.627B |
| September 21, 2026 | 1.658B |
| September 18, 2026 | 1.683B |
| September 17, 2026 | 1.657B |
| September 16, 2026 | 1.494B |
| September 15, 2026 | 1.495B |
| September 14, 2026 | 1.594B |
| September 11, 2026 | 1.569B |
| September 10, 2026 | 1.551B |
| September 09, 2026 | 1.680B |
| September 08, 2026 | 1.526B |
| September 04, 2026 | 1.422B |
| September 03, 2026 | 1.425B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Silence Therapeutics Plc | 853.12M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -20.99M |
| Mereo BioPharma Group Plc | 23.19M |
| HemoGenyx Pharmaceuticals Plc | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.826M |
| Total Expenses (Quarterly) | 9.826M |
| EPS Diluted (Quarterly) | -0.3112 |
| Earnings Yield | -39.45% |
| Normalized Earnings Yield | -34.10 |